MassDevice

Quick Launch Program for Micro Medical Production

July 30, 2019 By MassDevice Leave a Comment

By Lindsay Mann, Director of Sales & Marketing For OEMs who need a rapid prototype of their new medical device design, there are plenty of vendors to choose from. But for OEMs who are ready to … [Read More...]

Connecting the Next Generation of Medical Data and Devices to Improve Patient Outcomes

July 29, 2019 By MassDevice Leave a Comment

Every day, hospitals and doctors collect infinite amounts of data on individual patients, diseases and medical procedures. The rise of a new generation of robotic, precision, and surgical devices has … [Read More...]

Outcome-based Pricing Initiatives in the Healthcare Industry

July 11, 2019 By MassDevice Leave a Comment

By Joe Miles - Global Vice President, Life Sciences (SAP Industries) and Bob Steller - Industry Principle, Life Sciences (Vistex) A distorted reimbursement model has driven healthcare costs ever … [Read More...]

ConforMIS sues Zimmer Biomet for alleged patent infringement

ConforMIS (NSDQ:CFMS) has sued Zimmer Biomet (NYSE:ZBH) alleging infringement of four different … [Read More...]

Department of Justice clears Misonix in China FPCA probe

Misonix (NSDQ:MSON) said last week that the U.S. Department of Justice has dropped its inquiry into … [Read More...]

Zoll loses bid to dismiss LifeVest lawsuit

A federal judge has denied Asahi Kasei (TYO:3407) subsidiary Zoll Medical's motion to toss out a … [Read More...]

BD sues Stryker over PureWick catheter patents

Becton Dickinson (NYSE:BDX) this week levied a lawsuit against Stryker (NYSE:SYK), alleging … [Read More...]

Ex-Oriole DeCinces draws time served on insider trading conviction

A federal judge in California reportedly sentenced former professional baseball player Doug DeCinces … [Read More...]

Denmark’s Ambu settles U.S. trade violations for $3.3 million

Ambu A/S will pay $3.3 million to resolve allegations that it manufactured products in China and … [Read More...]

Judge tosses 5,000 warming-device lawsuits filed against 3M

This story has been updated with a comment from Augustine Surgical and the plaintiffs' … [Read More...]

3M funds Acelity buyout with $3.3B debt offering

3M (NYSE:MMM) is planning to finance its $6.7 billion acquisition of Acelity in part with a $3.3 billion debt offering. Maplewood, Minn.-based 3M, which announced its purchase of wound care giant Acelity in May, launched a four-part bond sale yesterday. 3M expects to finance the Acelity buyout with all of the net proceeds from the […]

Boston Scientific closes $4B BTG purchase

Boston Scientific (NYSE:BSX) said today that it finished its $4 billion acquisition of BTG (LN:BTG). The Marlborough, Mass.-based medtech giant reported that the transaction will be immaterial to adjusted earnings per share this year, thanks to – among other factors – the deal closing later than initially anticipated. To satisfy antitrust regulators, Boston Scientific is […]

UK regulators OK Boston Scientific’s $4B BTG buyout

British regulators have approved Boston Scientific’s (NYSE:BSX) $4 billion bid to buy BTG (LN:BTG), the companies announced today in regulatory filings. The deal, approved by the U.S. Federal Trade Commission on August 7, will close on Monday. The High Court of Justice in England and Wales agreed to the takeover following a hearing today. Boston […]

UK antitrust regulators probe Kohlberg’s Nelipak-Bemis merger

Antitrust regulators in the U.K. yesterday opened a probe into the planned merger of Nelipak and Bemis Healthcare Packaging Europe by private equity shop Kohlberg. The PE giant acquired Cranston, R.I.-based Nelipak, which manufactures rigid healthcare packaging used in Class II and Class III medical devices and pharma drug-delivery products, in early July for an undisclosed amount. Get […]

AtriCure closes $300m SentreHeart buyout

AtriCure (NSDQ:ATRC) said yesterday that it closed the $300 million buyout of SentreHeart and its Lariat left atrial appendage closure device. The offer included $40 million in up-front cash and stock, plus $140 million in clinical and regulatory milestones and $120 million in reimbursement milestones, all payable in cash and stock, Mason, Ohio-based AtriCure said when the […]

Stryker puts up $52m for TSO3

Stryker (NYSE:SYK) today agreed to pay $52 million to acquire TSO3 (TSX:TOS) and its Sterizone VP4 sterilizer. The C43¢-per-share offer works out to about C$68.4 million ($51.7 million), representing an 18% premium on the 30-day volume-weighted average share price, Quebec City-based TSO3 said. “TSO3‘s board of directors and management believe that this transaction provides the best […]

AtriCure offers $300m for SentreHeart

AtriCure (NSDQ:ATRC) said today that it put up a $300 million offer for SentreHeart and its Lariat left atrial appendage closure device. Redwood City, Calif.-based SentreHeart has enrolled 535 patients in the Amaze trial comparing Lariat and pulmonary vein isolation with PVI alone in treating atrial fibrillation. Today AtriCure said it expects the study tor each […]